<?xml version="1.0" encoding="UTF-8"?>
<p id="p0200">Amantadine and rimantadine can prevent the virus from shelling in the cytoplasm, thus inhibiting the transmission of virus offspring [
 <xref rid="bib118" ref-type="bibr">118</xref>]. Although developed for many years, it has been reported frequently that they are ineffective in clinical treatment due to drug resistance of almost all currently circulating IAVs [
 <xref rid="bib119" ref-type="bibr">119</xref>]. Furthermore, they have a relatively large side effect on the human central nervous system, thus are no longer recommended by WHO as the first choice of anti-influenza drugs for the treatment or prophylaxis of influenza [
 <xref rid="bib118" ref-type="bibr">118</xref>].
</p>
